Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brice

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Hematology and Cell Therapy|February 1, 1997
Peripheral blood stem cell CD34+ autologous transplant in relapsed follicular lymphomaG H Marin, L Dal Cortivo, J M Cayuela, et al.
The British Journal of Dermatology|October 20, 2018
Thymic localization of erythrodermic cutaneous T-cell lymphomaP Bonnet, M Battistella, J-D Bouaziz, et al.
Leukemia|March 31, 1998
Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'AdulteP Brice, D Cazals, N Mounier, et al.
The British Journal of Dermatology|October 18, 2018
Association of autoimmunity and long-term complete remission in patients with Sézary syndrome treated with mogamulizumabP Bonnet, M Battistella, M Roelens, et al.
Hematological Oncology|December 28, 2024
One-Day Brentuximab-Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin LymphomaH Moatti, P Brice, M-C Laroque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study GroupP Brice, M Divine, D Simon, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 7, 2014
Ofatumumab in refractory chronic lymphocytic leukemia: experience through the French early access programJ Dupuis, P Brice, S François, et al.
Blood|March 25, 2000
Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trialC Fermé, C Sebban, C Hennequin, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Factors affecting hematopoietic recovery after autologous peripheral blood progenitor-cell transplantation in aggressive non-Hodgkin's lymphoma: a prospective study of 123 patientsA M Langouët, P Brice, D Simon, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 5, 2019
Alopecic patches of the scalp: a variant of primary cutaneous follicle centre B-cell lymphoma reported in a series of 14 casesA de Masson, J-D Bouaziz, C Ram-Wolff, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Hematology and Cell Therapy|February 1, 1997
Peripheral blood stem cell CD34+ autologous transplant in relapsed follicular lymphomaG H Marin, L Dal Cortivo, J M Cayuela, et al.
The British Journal of Dermatology|October 20, 2018
Thymic localization of erythrodermic cutaneous T-cell lymphomaP Bonnet, M Battistella, J-D Bouaziz, et al.
Leukemia|March 31, 1998
Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'AdulteP Brice, D Cazals, N Mounier, et al.
The British Journal of Dermatology|October 18, 2018
Association of autoimmunity and long-term complete remission in patients with Sézary syndrome treated with mogamulizumabP Bonnet, M Battistella, M Roelens, et al.
Hematological Oncology|December 28, 2024
One-Day Brentuximab-Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin LymphomaH Moatti, P Brice, M-C Laroque, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study GroupP Brice, M Divine, D Simon, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 7, 2014
Ofatumumab in refractory chronic lymphocytic leukemia: experience through the French early access programJ Dupuis, P Brice, S François, et al.
Blood|March 25, 2000
Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trialC Fermé, C Sebban, C Hennequin, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|June 26, 2001
Factors affecting hematopoietic recovery after autologous peripheral blood progenitor-cell transplantation in aggressive non-Hodgkin's lymphoma: a prospective study of 123 patientsA M Langouët, P Brice, D Simon, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 5, 2019
Alopecic patches of the scalp: a variant of primary cutaneous follicle centre B-cell lymphoma reported in a series of 14 casesA de Masson, J-D Bouaziz, C Ram-Wolff, et al.
Pageof 15